vs
ASP Isotopes Inc.（ASPI）与Foghorn Therapeutics Inc.（FHTX）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是Foghorn Therapeutics Inc.的1.8倍（$16.7M vs $9.2M），ASP Isotopes Inc.同比增速更快（1295.7% vs 223.8%）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
ASPI vs FHTX — 直观对比
营收规模更大
ASPI
是对方的1.8倍
$9.2M
营收增速更快
ASPI
高出1071.9%
223.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $9.2M |
| 净利润 | — | $-21.7M |
| 毛利率 | 12.5% | — |
| 营业利润率 | — | -258.2% |
| 净利率 | — | -234.3% |
| 营收同比 | 1295.7% | 223.8% |
| 净利润同比 | -586.8% | -11.1% |
| 每股收益（稀释后） | — | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPIFHTX
| Q4 25 | $16.7M | $9.2M | ||
| Q3 25 | $4.9M | $8.2M | ||
| Q2 25 | — | $7.6M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $5.0M |
净利润ASPIFHTX
| Q4 25 | — | $-21.7M | ||
| Q3 25 | $-12.9M | $-15.8M | ||
| Q2 25 | — | $-17.9M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-19.5M | ||
| Q3 24 | — | $-19.1M | ||
| Q2 24 | — | $-23.0M | ||
| Q1 24 | — | $-25.0M |
毛利率ASPIFHTX
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ASPIFHTX
| Q4 25 | — | -258.2% | ||
| Q3 25 | -306.1% | -226.9% | ||
| Q2 25 | — | -279.2% | ||
| Q1 25 | — | -385.0% | ||
| Q4 24 | — | -840.5% | ||
| Q3 24 | — | -305.5% | ||
| Q2 24 | — | -386.6% | ||
| Q1 24 | — | -558.3% |
净利率ASPIFHTX
| Q4 25 | — | -234.3% | ||
| Q3 25 | -263.7% | -194.4% | ||
| Q2 25 | — | -237.3% | ||
| Q1 25 | — | -316.4% | ||
| Q4 24 | — | -682.9% | ||
| Q3 24 | — | -244.9% | ||
| Q2 24 | — | -333.6% | ||
| Q1 24 | — | -495.4% |
每股收益（稀释后）ASPIFHTX
| Q4 25 | — | $-0.35 | ||
| Q3 25 | $-0.15 | $-0.25 | ||
| Q2 25 | — | $-0.28 | ||
| Q1 25 | — | $-0.30 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.45 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $80.9M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $-108.5M |
| 总资产 | $498.0M | $198.1M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPIFHTX
| Q4 25 | $333.3M | $80.9M | ||
| Q3 25 | $113.9M | $89.3M | ||
| Q2 25 | — | $72.6M | ||
| Q1 25 | — | $61.0M | ||
| Q4 24 | — | $55.5M | ||
| Q3 24 | — | $57.7M | ||
| Q2 24 | — | $138.9M | ||
| Q1 24 | — | $79.3M |
总债务ASPIFHTX
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASPIFHTX
| Q4 25 | $204.2M | $-108.5M | ||
| Q3 25 | $74.1M | $-89.7M | ||
| Q2 25 | — | $-76.7M | ||
| Q1 25 | — | $-61.7M | ||
| Q4 24 | — | $-45.5M | ||
| Q3 24 | — | $-28.3M | ||
| Q2 24 | — | $-14.3M | ||
| Q1 24 | — | $-97.5M |
总资产ASPIFHTX
| Q4 25 | $498.0M | $198.1M | ||
| Q3 25 | $225.9M | $205.0M | ||
| Q2 25 | — | $226.2M | ||
| Q1 25 | — | $258.7M | ||
| Q4 24 | — | $284.0M | ||
| Q3 24 | — | $308.4M | ||
| Q2 24 | — | $328.6M | ||
| Q1 24 | — | $255.0M |
负债/权益比ASPIFHTX
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | — |
| 自由现金流率自由现金流/营收 | -284.7% | — |
| 资本支出强度资本支出/营收 | 57.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASPIFHTX
| Q4 25 | $-37.8M | $-22.3M | ||
| Q3 25 | $-8.9M | $-18.9M | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | — | $-24.5M | ||
| Q3 24 | — | $-21.0M | ||
| Q2 24 | — | $-25.5M | ||
| Q1 24 | — | $-29.3M |
自由现金流ASPIFHTX
| Q4 25 | $-47.4M | — | ||
| Q3 25 | $-12.0M | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | — | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-25.6M | ||
| Q1 24 | — | $-29.4M |
自由现金流率ASPIFHTX
| Q4 25 | -284.7% | — | ||
| Q3 25 | -245.5% | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | — | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | — | -371.0% | ||
| Q1 24 | — | -583.1% |
资本支出强度ASPIFHTX
| Q4 25 | 57.9% | 0.0% | ||
| Q3 25 | 64.4% | 0.0% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 2.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
